Aimfinity Investment CORP. I 8-K Filing

Key Financial Figures

• $11.50 — ordinary share at an exercise price of $11.50 AIMUF OTC Market Group, Inc. New
• $500 — s trust account (the " Trust Account ") $500 for each one-month extension. On Decem
• $10.00 — rdinary shares at a conversion price of $10.00 per share. The Note was issued pursuant

Filing Documents

• ea0271310-8k425_aimfin1.htm (8-K) — 48KB
• ea027131001ex10-1_aimfinity1.htm (EX-10.1) — 33KB
• ea027131001ex99-1_aimfinity1.htm (EX-99.1) — 15KB
• ex99-1_001.jpg (GRAPHIC) — 13KB
• 0001213900-25-126564.txt ( ) — 352KB
• aimtf-20251228.xsd (EX-101.SCH) — 4KB
• aimtf-20251228_def.xml (EX-101.DEF) — 27KB
• aimtf-20251228_lab.xml (EX-101.LAB) — 38KB
• aimtf-20251228_pre.xml (EX-101.PRE) — 26KB
• ea0271310-8k425_aimfin1_htm.xml (XML) — 7KB

03 Creation of a Direct Financial Obligation or an Obligation

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant On October 27, 2025, Aimfinity Investment Corp. I, a Cayman Islands exempted company (the " Company " or " AIMA "), held an extraordinary general meeting (the " EGM "), where the shareholders of the Company approved an amendment (the " Extension Amendment ") to the Company's fourth amended and restated memorandum and articles of associations (the " Charter ") to allow the Company until October 28, 2025 to consummate an initial business combination and may elect to extend the period to consummate an initial business combination up to nine times, each by an additional one-month period (each, a " Monthly Extension "), for a total of up to nine months to July 28, 2026, by depositing into the Company's trust account (the " Trust Account ") $500 for each one-month extension. On December 28, 2025, the Company issued an unsecured promissory note of $500 (the " Note ") to I-Fa Chang, a member and manager of Aimfinity Investment LLC, the sponsor of the company (the " Sponsor "), as the Sponsor's designee, to evidence the payments made for $500 (the " New Monthly Extension Payment ") to be deposited into the Trust Account for the public shareholders, which enables the Company to extend the period of time it has to consummate its initial business combination by one month from December 28, 2025 to January 28, 2026 (the " New Extension "). The New Extension is the third of the up to nine Monthly Extensions permitted under the Extension Amendment. Pursuant to the Note, and a certain exchange agreement, dated April 8, 2025, by and among the Company, Mr. Chang and certain other parties to the Merger Agreement, upon the closing of the Business Combination (as defined below) by and between the Company and Docter Inc., a Delaware corporation, the balance of the Note, unless repaid in part or in full, will automatically be exchanged for such number of PubCo (as

02 Unregistered Sales of Equity Securities

Item 3.02 Unregistered Sales of Equity Securities. The information disclosed under Item 2.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02 to the extent required herein.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On December 30, 2025, the Company issued a press release (the " Press Release ") announcing the New Extension. A copy of the Press Release is furnished as Exhibit 99.1 hereto. The information in this Item 7.01 and Exhibit 99.1 furnished hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing. IMPORTANT NOTICES As disclosed previously on the Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on October 16, 2023, on October 13, 2023, AIMA entered into that certain Merger Agreement, with Docter, Aimfinity Investment Merger Sub I (the "Purchaser" or "PubCo"), and Aimfinity Investment Merger Sub II, Inc. (the "Merger Sub"), pursuant to which AIMA will complete a business combination (the "Business Combination") with Docter that involves a reincorporation merger and an acquisition merger. 1 This Current Report on Form 8-K contains certain "forward-looking about the proposed transactions described above, and the parties' perspectives and expectations, are forward-looking statements. Such statements include, but are not limited to, statements regarding the proposed transactions, including the anticipated initial enterprise value and post-closing equity value, the benefits of the proposed transaction, integration plans, expected synergies and revenue opportunities, anticipated future financial and operating performance and results, including estimates for growth, the expected management and governance of the combined company, and the expected timing o

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Promissory Note, dated December 28, 2025, issued by Aimfinity Investment Corp. I to I-Fa Chang 99.1 Press Release, dated December 30, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 3

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Aimfinity Investment Corp. I Date: December 30, 2025 By: /s/ I-Fa Chang Name: I-Fa Chang Title: Chief Executive Officer 4

View Full Filing

View this 8-K filing on SEC EDGAR